Abstract A072: Preliminary results of ASTX660, a novel non-peptidomimetic cIAP1/2 and XIAP antagonist, in 107 patients with solid tumors or lymphoma

Antoine Hollebecque, Monica Mita, Marc Webster et al.|Molecular Cancer Therapeutics|2019

Cited by 2